Accessibility Menu
 
InflaRx logo

InflaRx

(NASDAQ) IFRX

Current Price$0.89
Market Cap$65.28M
Since IPO (2017)-94%
5 Year-78%
1 Year-14%
1 Month-2%

InflaRx Financials at a Glance

Market Cap

$65.28M

Revenue (TTM)

$28.17K

Net Income (TTM)

$43.83M

EPS (TTM)

$0.00

P/E Ratio

-0.86

Dividend

$0.00

Beta (Volatility)

0.87 (Low)

Price

$0.89

Volume

0

Open

$0.91

Previous Close

$0.89

Daily Range

$0.87 - $0.91

52-Week Range

$0.71 - $1.94

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About InflaRx

Industry

Biotechnology

Employees

65

CEO

Niels Christoph Riedemann, MD, PhD

Headquarters

Jena, 07745, DE

IFRX Financials

Key Financial Metrics (TTM)

Gross Margin

-261%

Operating Margin

-1736%

Net Income Margin

-1556%

Return on Equity

0%

Return on Capital

-1%

Return on Assets

-79%

Earnings Yield

-1.16%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$65.28M

Shares Outstanding

72.29M

Volume

0

Short Interest

0.00%

Avg. Volume

412.93K

Financials (TTM)

Gross Profit

$7.36M

Operating Income

$48.91M

EBITDA

$48.50M

Operating Cash Flow

$33.92M

Capital Expenditure

$111.13K

Free Cash Flow

$34.03M

Cash & ST Invst.

$46.44M

Total Debt

$897.53K

InflaRx Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$35.09K

-8195.3%

Gross Profit

$5.01M

-77.6%

Gross Margin

142.77%

N/A

Market Cap

$65.28M

N/A

Market Cap/Employee

$882.17K

N/A

Employees

74

N/A

Net Income

$8.84M

-73.0%

EBITDA

$13.97M

-179.6%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$45.54M

+159.2%

Accounts Receivable

$1.43M

N/A

Inventory

$0.00

-100.0%

Long Term Debt

$640.70K

+60.5%

Short Term Debt

$256.83K

-36.7%

Return on Assets

-79.42%

N/A

Return on Invested Capital

-1.16%

N/A

Free Cash Flow

$3.31M

+72.2%

Operating Cash Flow

$3.31M

+72.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
IMAImageneBio Inc
$5.05+1.00%
MGXMetagenomi, Inc. Common Stock
$1.34+0.00%
ATYRaTyr Pharma, Inc.
$0.85+9.08%
KLRSKalaris Therapeutics Inc
$5.93+2.86%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$43.23+0.04%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.77+0.05%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$77.45-0.04%
CYCNCyclerion Therapeutics
$6.38+3.12%

Questions About IFRX

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.